In search for the molecular basis by which transgenic AR expression and p16INK4a deletion regulate prostate tumorigenesis, we performed RNA-sequencing analysis to examine the global transcriptome profiles in the mouse prostate tumor samples. This evidence concerns the gene CDKN2A and prostate neoplasm.